Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33)
קרן | National Institute on Drug Abuse/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 17/12/2021 |
פקולטה | Life Sciences, Medicine, Social Sciences |
תיאור | The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes.
Funding: R21 $125,000 per year; R33 $250,000 per year Duration: R21 2 years; R33 3 years
Research Authority due date: 10 days prior to submission LOI (ncouraged) due dates: 24.5.19, 18.11.19, 24.5.20, 18.11.20, 24.5.21, 17.11.21 Full proposal due dates: 24.6.19, 18.12.19, 24.6.20, 18.12.20, 24.6.21, 17.12.21 |
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 12/05/2019 |